Olanzapine Injection package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Olanzapine IM injection Olanzapine IM is a short-acting formulation that may be given to adults with schizophrenia or bipolar I mania if they have become agitated. The usual dosage of olanzapine IM is 10 mg as a single dose. Smaller dosages (5 mg or 7.5 mg) can be given if these are ...
The efficacy of intramuscular olanzapine for injection in controllingagitation in these disorders was demonstrated in a dose range of 2.5 mg to 10 mg. The recommended dose in these patients is 10 mg. A lower dose of 5 or7.5 mg may be considered when clinical factors warrant [seeClinical Studi...
Patients must be examined for 3 hours after receiving an injection. Olanzapine may increase prolactin levels. Increased prolactin levels may manifest as abnormal menstruation, sexual dysfunction, and breast enlargement. QUESTION Schizophrenia is the most disabling mental illness. See Answer What is the...
A dose of 5 mg/injection should be considered for geriatric patients or when other clinical factors warrant.A lower dose of 2.5 mg/injection should be considered for patients who otherwise might be debilitated, be predisposed to hypotensive reactions, or be morepharmacodynamically sensitive to olan...
The objective of this study was to confirm the efficacy of rapid-acting IM olanzapine 10 mg was greater than IM placebo in patients with exacerbation of schizophrenia with acute psychotic agitation by comparing changes from baseline to 2 hours after the first IM injection, as measured by the ...
Patients may develop severe sedation,coma, and or delirium after an injection of extended release olanzapine. Patients must be examined for 3 hours after receiving an injection. Olanzapine may increaseprolactinlevels. Increased prolactin levels may manifest as abnormal menstruation, sexual dysfunction, and...
The information below for olanzapine is derived from a clinical trial database for olanzapine consisting of 10,504 adult patients with approximately 4,765 patient-years of exposure to olanzapine plus 722 patients with exposure to intramuscular olanzapine for injection. This database includes: (1) 2...
ZYPREXA RELPREVV should be administered by a healthcare professional every 2 to 4 weeks by deep intramuscular gluteal injection using a 19-gauge, 1.5-inch needle. Following insertion of the needle into the muscle, aspiration should be maintained for several seconds to ensure that no blood isdrawn...
A dose of 5 mg/injection should be considered for geriatric patients or when other clinical factors warrant.A lower dose of 2.5 mg/injection should be considered for patients who otherwise might be debilitated, be predisposed to hypotensive reactions, or be morepharmacodynamically sensitive to olan...